Leverage Analysis Stories

Local Bounti Corp (USA Stocks: LOCL), a player in the Farm Products industry, is currently in a significant debt position. As of September, the company has a long-term debt of 119.8M, which is a substantial figure considering its total assets of 278.7M. This debt has led to a net interest income loss of 16.7M, further impacting the company's financial health.

Rhythm Pharmaceuticals (NASDAQ: RYTM), a prominent player in the Biotechnology industry, is in the spotlight as we move into September. Despite posting a net income loss of $181.1M and a free cash flow deficit of $177.7M, the company's robust financial health is evident in its total stockholder equity of $264.3M, outweighing its total liabilities of $118.2M. The company's change in cash stands at an impressive $68.4M, while the naive expected forecast value is set at 26.15.

Powell Industries, a leader in the Electrical Equipment & Parts industry, has been demonstrating a strong financial performance, even amidst a modest market downturn. With a total revenue of 532.6M, an income before tax of 9.8M, and a solid net tangible assets of 296.2M, the company's robust financial health is evident. From a leverage perspective, Powell's prudent management of capital is noteworthy, with capital expenditures at a minimal 2.5M and deferred long-term liabilities at a manageable 7.7M.

Powell Industries currently has $2.32 million in liabilities, with a Debt to Equity (D/E) ratio of 0.01. This may suggest that Powell Industries is not fully leveraging its borrowing potential. The asset utilization indicator refers to the revenue generated for every dollar of assets reported by a company.

The company in question, Symbotic, maintains a current ratio of 1.14. This indicates a potential difficulty in meeting its financial obligations when they become due. Debt can serve as a temporary aid for Symbotic, until the point where it struggles to pay it off, either through raising new capital or generating free cash flow.

Evelo Biosciences currently has liabilities amounting to 51.14 million, with a Debt to Equity (D/E) ratio of 1.55. This ratio is roughly average when compared to similar companies. A useful method to evaluate Evelo's asset utilization is by examining the profit generated for each dollar of reported assets.

Vyne Therapeutics, a prominent player in the Biotechnology industry, has seen a significant surge in its stock price, defying the modest market downturn. The stock has seen a 13.59% price percent change, a substantial increase that signals potential for considerable returns. However, it's important to note that Vyne's financial health presents some concerns.

Vyne Therapeutics, a notable player in the Biotechnology industry, has been a topic of interest for investors on the NASDAQ exchange. The company, with a total of 3.2M common stock shares outstanding, has shown some intriguing financial figures. With a total stockholder equity of 31.2M and other stockholder equity amounting to a staggering 692.3M, Vyne Therapeutics seems to have a solid financial foundation.

The company currently holds 3.08 million in liabilities, with a Debt to Equity (D/E) ratio of 0.04. This may suggest that American Superconductor is not leveraging borrowing sufficiently. Our trading advice tool can cross-verify the current analyst consensus on American Superconductor and analyze the company's potential to grow in the present economic cycle.

Rigorous look on American

American Superconductor (AMSC) presents an interesting case for investors looking at leverage opportunities.

Tupperware Brands (TUP), a key player in the Household Goods industry, has shown significant financial leverage in its recent financial reports. The company's Net Invested Capital stands at a substantial $705.4M, indicating a significant amount of capital invested in the business. However, Tupperware's financial health is somewhat concerning, with Non-Current Liabilities Totaling $811.6M and a Net Debt of $595.3M.